Cell Transformation, Viral
"Cell Transformation, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus.
|Cell Transformation, Viral
- Cell Transformation, Viral
- Cell Transformations, Viral
- Transformations, Viral Cell
- Viral Cell Transformations
- Transformation, Viral Cell
- Viral Cell Transformation
Below are MeSH descriptors whose meaning is more general than "Cell Transformation, Viral".
Below are MeSH descriptors whose meaning is more specific than "Cell Transformation, Viral".
This graph shows the total number of publications written about "Cell Transformation, Viral" by people in this website by year, and whether "Cell Transformation, Viral" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Cell Transformation, Viral" by people in Profiles.
Abboodi F, Buckhaults P, Altomare D, Liu C, Hosseinipour M, Banister CE, Creek KE, Pirisi L. HPV-inactive cell populations arise from HPV16-transformed human keratinocytes after p53 knockout. Virology. 2021 02; 554:9-16.
Dai L, Trillo-Tinoco J, Chen Y, Bonstaff K, Del Valle L, Parsons C, Ochoa AC, Zabaleta J, Toole BP, Qin Z. CD147 and downstream ADAMTSs promote the tumorigenicity of Kaposi's sarcoma-associated herpesvirus infected endothelial cells. Oncotarget. 2016 Jan 26; 7(4):3806-18.
Kagawa S, Natsuizaka M, Whelan KA, Facompre N, Naganuma S, Ohashi S, Kinugasa H, Egloff AM, Basu D, Gimotty PA, Klein-Szanto AJ, Bass AJ, Wong KK, Diehl JA, Rustgi AK, Nakagawa H. Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor activities. Oncogene. 2015 Apr 30; 34(18):2347-59.
Dai L, Bai L, Lu Y, Xu Z, Reiss K, Del Valle L, Kaleeba J, Toole BP, Parsons C, Qin Z. Emmprin and KSHV: new partners in viral cancer pathogenesis. Cancer Lett. 2013 Sep 01; 337(2):161-6.
Sorokina EM, Merlo JJ, Tsygankov AY. Molecular mechanisms of the effect of herpesvirus saimiri protein StpC on the signaling pathway leading to NF-kappaB activation. J Biol Chem. 2004 Apr 02; 279(14):13469-77.
Sementchenko VI, Watson DK. Ets target genes: past, present and future. Oncogene. 2000 Dec 18; 19(55):6533-48.
Argraves KM, Battey FD, MacCalman CD, McCrae KR, Gåfvels M, Kozarsky KF, Chappell DA, Strauss JF, Strickland DK. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes. J Biol Chem. 1995 Nov 03; 270(44):26550-7.
Andrews DF, Lilly MB, Tompkins CK, Singer JW. Sodium vanadate, a tyrosine phosphatase inhibitor, affects expression of hematopoietic growth factors and extracellular matrix RNAs in SV40-transformed human marrow stromal cells. Exp Hematol. 1992 May; 20(4):449-53.
Pharr PN, Ogawa M. Enhancement of the proliferation of murine fetal liver erythroid progenitors by infection with Harvey sarcoma virus. Leukemia. 1990 Mar; 4(3):210-5.
Watson DK, Ascione R, Papas TS. Molecular analysis of the ets genes and their products. Crit Rev Oncog. 1990; 1(4):409-36.